Testosterone and sex hormone-binding globulin could do much to reduce atherosclerotic risk in postmenopausal women not on hormone replacement therapy.
This reduction could be the result of higher total testosterone and sex hormone-binding globulin being inversely related to carotid atherosclerosis in such women.
Researchers at four leading US institutions – Johns Hopkins University School of Medicine, Baltimore, Maryland, Wisconsin School of Medicine, Milwaukee, Wisconsin, Wake Forest University School of Medicine, Winston-Salem, North Carolina and the University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania – conducted a case-control study in 1987-1992 which compared endogenous postmenopausal hormone levels in women in the Atherosclerosis Risk in Communities (ARIC) cohort with and without significant carotid atherosclerosis.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!